More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows–raising questions about how societal views of women’s weight may influence use of these medications and underscoring the need to better understand how the drugs may affect fertility, pregnancy, and longer-term health outcomes, researchers say.
